Skip to main content

Set discontinuation phase

In the configuration of subject phase availability, you have the option to designate specific phases where subjects may be discontinued from the study. By defining these potential exit points, this feature introduces a layer of flexibility, accommodating the reality that subjects may need to end their participation at some stages.

To set discontinuation phases

  1. In the IWRS application header, select the TREATMENT DESIGN tab.

  2. On the page that opens, in the left pane, select the Subject Phase subtab.

    Accessing subject phase management
    Figure 1. Accessing subject phase management

  3. On the Subject Phase page that opens, select Set Phase settings_icon_01.png and then Set Discontinue Phase.

    Selecting option to set discontinue phase
    Figure 2. Selecting option to set discontinue phase

  4. In the Set Phase Support Discontinue Subject dialog that appears, select checkboxes next to the phases you want to make available for the subject discontinuation.

    Setting discontinue phases
    Figure 3. Setting discontinue phases

  5. Select save_button_red.png to save the implemented changes.

Once saved, the selected phases are set for possible subject discontinuation.

In this section:

A specific phase that a subject has to complete in the course of a clinical trial to move further to the next phase. For instance, Screening, Enrolled, Randomized, and others.

subject_phase.png

In eClinical, subject phases are designed individually for each study via the SD application, although they are referenced in others, like IWRS or EDC.